AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20709856 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1291
Study 19452729 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic laryngoscope (EL)
Number of subjects: 92
Study 19452729 — intervention group
Group type: COMPARATOR
Intervention: Self-retaining laryngoscope (SRM)
Number of subjects: 92
Study 16102079 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer
Number of subjects: 17
Study 16102079 — intervention group
Group type: EXPERIMENTAL
Intervention: Cav-Clean
Number of subjects: 17
Study 16102079 — intervention group
Group type: COMPARATOR
Intervention: Control (dental adhesive only)
Number of subjects: 17
Study 14620219 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding a container of sucrose
Number of subjects: 76
Study 14620219 — intervention group
Group type: COMPARATOR
Intervention: Not holding a container of sucrose (control)
Number of subjects: 76
Study 10593548 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment
Number of subjects: 10
Study 10593548 — intervention group
Group type: COMPARATOR
Intervention: Control group (unmedicated subjects with migraine headache)
Number of subjects: 10
Study 8763594 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg 12-hourly for 8 days
Number of subjects: 280
Study 8763594 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate 500 mg 8-hourly for 8 days
Number of subjects: 280
Study 8763594 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 280
Study 8763594 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 280
Study 1678033 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 4000 U calcium heparin over 4 hours
Number of subjects: 8
Study 1678033 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of 12,500 U calcium heparin
Number of subjects: 8
Study 6953729 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural pethidine (20 or 60 mg)
Number of subjects: 6
Study 6953729 — intervention group
Group type: COMPARATOR
Intervention: Parenteral pethidine (2 mg/kg body weight intramuscularly)
Number of subjects: 6
Study 31606398 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered CBT
Number of subjects: 273
Study 31606398 — intervention group
Group type: COMPARATOR
Intervention: Internet-delivered pain education
Number of subjects: 273
Study 29959448 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric cross-education (CE)
Number of subjects: 48
Study 29959448 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric cross-education (CE)
Number of subjects: 48
Study 29959448 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 29959448 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 48
Study 28495412 — intervention group
Group type: EXPERIMENTAL
Intervention: Topaz® microdebridement
Number of subjects: 36
Study 28495412 — intervention group
Group type: COMPARATOR
Intervention: Surgical decompression
Number of subjects: 36
Study 25957574 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile coach based intervention (N = 840)
Number of subjects: 1680
Study 25957574 — intervention group
Group type: COMPARATOR
Intervention: Assessment only control group (N = 840)
Number of subjects: 1680
Study 23374328 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized progesterone (400 mg/day)
Number of subjects: 42
Study 23374328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 21397252 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow wave deprivation (SWD)
Number of subjects: 17
Study 18718971 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental quadriceps muscle pain induced by hypertonic saline (5.8%)
Number of subjects: 20
Study 18718971 — intervention group
Group type: COMPARATOR
Intervention: Control with isotonic saline (0.9%)
Number of subjects: 20
Study 17760544 — intervention group
Group type: EXPERIMENTAL
Intervention: MM + SRP
Number of subjects: 127
Study 17760544 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 127
Study 14509050 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupentixol
Number of subjects: 153
Study 14509050 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 153
Study 10611184 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU daily fixed-dose regimen of recombinant follicle stimulating hormone (FSH, Puregon)
Number of subjects: 138
Study 10611184 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 IU daily fixed-dose regimen of recombinant follicle stimulating hormone (FSH, Puregon)
Number of subjects: 138
Study 10611184 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 IU daily fixed-dose regimen of recombinant follicle stimulating hormone (FSH, Puregon) in 30-33 age class
Number of subjects: 138
Study 10611184 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU daily fixed-dose regimen of recombinant follicle stimulating hormone (FSH, Puregon) in 37-39 age class
Number of subjects: 138
Study 9104664 — intervention group
Group type: EXPERIMENTAL
Intervention: Research-based clinical handbook for continence care
Number of subjects: 0
Study 9104664 — intervention group
Group type: COMPARATOR
Intervention: Control group (no handbook)
Number of subjects: 0
Study 1359808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2.4 micrograms/kg
Number of subjects: 100
Study 1359808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.2 micrograms/kg
Number of subjects: 100
Study 1359808 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 100
Study 3510601 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide hydrochloride
Number of subjects: 425
Study 3510601 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 425
Study 3510601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 425
Study 29727719 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing-Stacking (BS)
Number of subjects: 14
Study 29727719 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive Spirometer (IS)
Number of subjects: 14
Study 26369589 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol MDPI 180 µg (2 inhalations × 90 µg/inhalation) 4 times/day for 12 weeks
Number of subjects: 654
Study 26369589 — intervention group
Group type: COMPARATOR
Intervention: Placebo MDPI
Number of subjects: 654
Study 26369589 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol MDPI 180 µg (2 inhalations × 90 µg/inhalation) as needed (PRN) during the 40-week open-label phase
Number of subjects: 654
Study 24799585 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing full drug coverage for nonwhite patients
Number of subjects: 0
Study 24799585 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing full drug coverage for white patients
Number of subjects: 0
Study 22672221 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic control (mean HbA1c decreased by 13% to 8 ± 1.6%)
Number of subjects: 27
Study 22672221 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic control (cholesterol decreased by 17% to 4.3 ± 1.3 mmol/L)
Number of subjects: 27
Study 22672221 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic control
Number of subjects: 27
Study 20199979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 plus carboplatin AUC 6
Number of subjects: 130
Study 20199979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 plus oxaliplatin 120 mg/m2
Number of subjects: 130
Study 20199979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed treatment
Number of subjects: 130
Study 18832488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 100
Study 18832488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 100
Study 18832488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16081445 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin and multimineral supplementation
Number of subjects: 910
Study 16081445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 910
Study 11777511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg
Number of subjects: 120
Study 11777511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 120
Study 11777511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 16 mg
Number of subjects: 120
Study 11777511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 10388143 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical disability
Number of subjects: 1104
Study 10388143 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical disability (limited to those in intact or partially-destroyed dwellings)
Number of subjects: 1104
Study 10388143 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and degree of damage to dwelling
Number of subjects: 1104
Study 8681492 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril, 25 mg three times a day for 7 days
Number of subjects: 7
Study 8681492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8681492 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 7
Study 2021381 — intervention group
Group type: EXPERIMENTAL
Intervention: False skin conductance feedback during CS presentation
Number of subjects: 0
Study 2021381 — intervention group
Group type: COMPARATOR
Intervention: Self-report and behavioral measures of UCS revaluation after conditioning
Number of subjects: 0
Study 6129867 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 136
Study 6129867 — intervention group
Group type: COMPARATOR
Intervention: Clemastine
Number of subjects: 136
Study 6129867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 31183797 — intervention group
Group type: EXPERIMENTAL
Intervention: neoClose® device
Number of subjects: 35
Study 31183797 — intervention group
Group type: COMPARATOR
Intervention: standard suture passer
Number of subjects: 35
Study 31086334 — intervention group
Group type: EXPERIMENTAL
Intervention: Imprisonment
Number of subjects: 111110
Study 31086334 — intervention group
Group type: COMPARATOR
Intervention: Probation
Number of subjects: 111110
Study 28222251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomethylation of LZTS2
Number of subjects: 295
Study 28222251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomethylation of NR6A1
Number of subjects: 295
Study 28222251 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation values below the median at both markers
Number of subjects: 295
Study 24408881 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous compression with Fixed cycling rate (SF)
Number of subjects: 108
Study 24408881 — intervention group
Group type: COMPARATOR
Intervention: Alternate compression with Adjusted cycling rate (AA)
Number of subjects: 108
Study 24297763 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy (12 hours)
Number of subjects: 12
Study 24297763 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (12 hours)
Number of subjects: 12
Study 22194152 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation
Number of subjects: 1813
Study 22194152 — intervention group
Group type: COMPARATOR
Intervention: Usual care (without referral to rehabilitation)
Number of subjects: 1813
Study 19192016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream containing 6.0% Stryphnodendron adstringens bark extract
Number of subjects: 0
Study 19192016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17943982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental roll with one mini-marshmallow
Number of subjects: 65
Study 17943982 — intervention group
Group type: COMPARATOR
Intervention: Flavored drink crystal dental rolls
Number of subjects: 65
Study 17943982 — intervention group
Group type: EXPERIMENTAL
Intervention: Marshmallow-flavored dental rolls
Number of subjects: 65
Study 16002033 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily IVR monitoring for 28 days
Number of subjects: 98
Study 16002033 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly IVR monitoring for 4 weeks
Number of subjects: 98
Study 16002033 — intervention group
Group type: COMPARATOR
Intervention: 28-day follow-up assessment with retrospective drinking reports
Number of subjects: 98
Study 12360595 — intervention group
Group type: EXPERIMENTAL
Intervention: Berodual
Number of subjects: 32
Study 12360595 — intervention group
Group type: EXPERIMENTAL
Intervention: Salgim
Number of subjects: 32
Study 9835059 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency (HF) words with differential strengthening during list presentation
Number of subjects: 0
Study 9835059 — intervention group
Group type: COMPARATOR
Intervention: Low frequency (LF) words
Number of subjects: 0
Study 7917196 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone therapy taper from 60 mg orally decreasing by 10 mg each day over 6 days
Number of subjects: 55
Study 7917196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2490831 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased treatment of hypertension (antihypertensive medication)
Number of subjects: 0
Study 2490831 — intervention group
Group type: EXPERIMENTAL
Intervention: Community control of hypertension
Number of subjects: 0
Study 2490831 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment of hypertension
Number of subjects: 0
Study 2490831 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors other than antihypertensive treatment
Number of subjects: 0
Study 7001039 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine prophylaxis administered at intervals of 3 months
Number of subjects: 0
Study 7001039 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine prophylaxis
Number of subjects: 0
Study 31542381 — intervention group
Group type: EXPERIMENTAL
Intervention: sealed meal and snack condition
Number of subjects: 62
Study 31542381 — intervention group
Group type: COMPARATOR
Intervention: pre‐opened meal and snack condition
Number of subjects: 62
Study 31542381 — intervention group
Group type: EXPERIMENTAL
Intervention: sealed breakfast
Number of subjects: 62
Study 31542381 — intervention group
Group type: EXPERIMENTAL
Intervention: high protein snack (cheese and biscuits)
Number of subjects: 62
Study 30037726 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR of 30 to 299 mg/g
Number of subjects: 3511
Study 30037726 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR ≥ 300 mg/g
Number of subjects: 3511
Study 28059560 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal sparing intensity-modulated radiotherapy (HS IMRT)
Number of subjects: 0
Study 28059560 — intervention group
Group type: COMPARATOR
Intervention: Conventional whole-brain radiotherapy (WBRT)
Number of subjects: 0
Study 24953533 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer reminders (ComRem)
Number of subjects: 213
Study 24953533 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal reminders (Postal)
Number of subjects: 213
Study 23414904 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 205
Study 23414904 — intervention group
Group type: COMPARATOR
Intervention: Control (no RIPC)
Number of subjects: 205
Study 21324607 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Ladder (AL) at 3 months post release
Number of subjects: 114
Study 21324607 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Ladder (AL) at baseline
Number of subjects: 114
Study 19352063 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA drink (0.4% BCAA, 4% carbohydrate; 1,500 mL/d)
Number of subjects: 8
Study 19352063 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (iso‐caloric)
Number of subjects: 8
Study 19352063 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA drink
Number of subjects: 8
Study 18186378 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination alone (OBS)
Number of subjects: 90
Study 18186378 — intervention group
Group type: COMPARATOR
Intervention: Appendiceal CT scan with clinical observation (CT)
Number of subjects: 90
Study 16331300 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo-energetic low-fat diet (20-25% fat energy, -600 kcal/day)
Number of subjects: 771
Study 16331300 — intervention group
Group type: COMPARATOR
Intervention: Hypo-energetic high-fat diet (40-45% fat energy, -600 kcal/day)
Number of subjects: 771
Study 16331300 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 771
Study 14668779 — intervention group
Group type: EXPERIMENTAL
Intervention: LIMA to LAD anastomosis with stress-induced ischemia
Number of subjects: 38
Study 14668779 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with luminal stenosis
Number of subjects: 38
Study 14668779 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ILAD without luminal stenosis
Number of subjects: 38
Study 14668779 — intervention group
Group type: COMPARATOR
Intervention: Control group (18 subjects without ischemia or stenosis)
Number of subjects: 38
Study 10321931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 40 mg/day
Number of subjects: 0
Study 10321931 — intervention group
Group type: COMPARATOR
Intervention: Etidronate and calcitonin (control)
Number of subjects: 0
Study 9110064 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (500 mg six times daily)
Number of subjects: 100
Study 9110064 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir (5 mg/kg once daily)
Number of subjects: 100
Study 1748537 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule
Number of subjects: 14
Study 1748537 — intervention group
Group type: COMPARATOR
Intervention: Liquid prepared from effervescent IP tablets
Number of subjects: 14
Study 1748537 — intervention group
Group type: COMPARATOR
Intervention: Film-coated tablet
Number of subjects: 14
Study 7183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers who consumed more food or liquids to avoid smoking and/or avoided related substances such as alcohol and coffee
Number of subjects: 24
Study 7183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers who attempted to reduce without a specific plan
Number of subjects: 24
Study 29484547 — intervention group
Group type: EXPERIMENTAL
Intervention: New complete dentures (T2)
Number of subjects: 32
Study 29484547 — intervention group
Group type: EXPERIMENTAL
Intervention: New complete dentures (T3)
Number of subjects: 32
Study 27578231 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron 4mg in 10mL of saline
Number of subjects: 100
Study 27578231 — intervention group
Group type: COMPARATOR
Intervention: 10mL of saline (placebo)
Number of subjects: 100
Study 24570141 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat overfeeding diet for 5 days
Number of subjects: 40
Study 24570141 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 40
Study 23378709 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fluence Q-switched Nd: YAG laser (QSNYL) at weekly intervals
Number of subjects: 60
Study 23378709 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 20% azelaic acid cream applied twice daily
Number of subjects: 60
Study 23378709 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low-fluence QSNYL and topical 20% azelaic acid cream
Number of subjects: 60
Study 20529547 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose potassium sodium hydrogen citrate (1 g/d)
Number of subjects: 72
Study 20529547 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose potassium sodium hydrogen citrate (2 g/d)
Number of subjects: 72
Study 20529547 — intervention group
Group type: COMPARATOR
Intervention: No potassium sodium hydrogen citrate (control group)
Number of subjects: 72
Study 20529547 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of PSHC (1 g/d and 2 g/d)
Number of subjects: 72
Study 18672630 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 382
Study 18672630 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 382
Study 15754988 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiducial marker fitting with parameter distribution model (PDM)
Number of subjects: 13
Study 12486491 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) 800 mg infusion
Number of subjects: 10
Study 12486491 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study 10351919 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 micrograms)
Number of subjects: 16
Study 10351919 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (200 micrograms)
Number of subjects: 16
Study 7572698 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA diet + weight loss (AHA + WL)
Number of subjects: 42
Study 7572698 — intervention group
Group type: COMPARATOR
Intervention: AHA diet + weight maintenance (AHA + WM)
Number of subjects: 42
Study 7572698 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month AHA diet
Number of subjects: 42
Study 1951552 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 50
Study 1951552 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 50
Study 6816132 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 6
Study 6816132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31634154 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEU
Number of subjects: 933
Study 31634154 — intervention group
Group type: COMPARATOR
Intervention: HUU
Number of subjects: 933
Study 31267965 — intervention group
Group type: EXPERIMENTAL
Intervention: Quizartinib
Number of subjects: 0
Study 31267965 — intervention group
Group type: COMPARATOR
Intervention: Salvage chemotherapy
Number of subjects: 0
Study 28254171 — intervention group
Group type: COMPARATOR
Intervention: Health Canada's food guide (control, n = 486)
Number of subjects: 919